iifl-logo

Dr Lal Pathlabs Ltd Share Price

2,777.8
(-1.21%)
Apr 29, 2025|03:53:39 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open2,835
  • Day's High2,851.6
  • 52 Wk High3,653.95
  • Prev. Close2,811.7
  • Day's Low2,752.6
  • 52 Wk Low 2,201.2
  • Turnover (lac)5,916.29
  • P/E47.22
  • Face Value10
  • Book Value286.76
  • EPS59.49
  • Mkt. Cap (Cr.)23,220.11
  • Div. Yield0.85
View All Historical Data
Loading...
  • Open3,022.65
  • Day's High3,032.4
  • Spot3,000.9
  • Prev. Close3,038.4
  • Day's Low2,969.75
  • ViewShort BuildUp
  • Market Lot300
  • OI(Chg %)7,500 (3.92%)
  • Roll Over%9.44
  • Roll Cost0.7
  • Traded Vol.3,77,100 (-43.83%)
View More Futures

Dr Lal Pathlabs Ltd KEY RATIOS

Sector

Healthcare

Open

2,835

Prev. Close

2,811.7

Turnover(Lac.)

5,916.29

Day's High

2,851.6

Day's Low

2,752.6

52 Week's High

3,653.95

52 Week's Low

2,201.2

Book Value

286.76

Face Value

10

Mkt Cap (₹ Cr.)

23,220.11

P/E

47.22

EPS

59.49

Divi. Yield

0.85

Dr Lal Pathlabs Ltd Corporate Action

10 May 2024

12:00 AM

AGM

Announcement Date: 10 May, 2024

arrow

18 Apr 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

30 Jan 2025

12:00 AM

Dividend

Dividend Amount: 6

Record Date: 05 Feb, 2025

arrow

Dr Lal Pathlabs Ltd NEWS AND UPDATE

Dr Lal PathLabs Reports 81.4% Profit Jump in Q4 Result
28 Apr 2025|12:38 PM

Dr Lal PathLabs declared a fourth interim dividend of ₹6 per share for 2025, reflecting its strong cash generation and shareholder remittance focus.

Read More
Dr. Lal PathLabs Q3 Profit Up 19% YoY, Announces ₹6 Dividend
31 Jan 2025|05:04 PM

The company declared a third interim dividend of ₹6 per share (60% on a face value of ₹10) for FY25.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Dr Lal Pathlabs Ltd SHAREHOLDING SNAPSHOT

30 Apr, 2025|06:15 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 1.85%

Foreign: 1.84%

Indian: 52.05%

Non-Promoter- 39.98%

Institutions: 39.98%

Non-Institutions: 5.83%

Custodian: 0.26%

Share Price

Dr Lal Pathlabs Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

83.48

83.37

83.35

83.35

Preference Capital

0

0

0

0

Reserves

1,816.18

1,606.5

1,388.77

1,133.74

Net Worth

1,899.66

1,689.87

1,472.12

1,217.09

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

1,872.7

1,490.55

1,273.59

1,024.04

yoy growth (%)

25.63

17.03

24.36

16.12

Raw materials

-446.31

-373.9

-286.86

-219.31

As % of sales

23.83

25.08

22.52

21.41

Employee costs

-320.22

-257.43

-232.06

-175.08

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

459.39

374.04

302.75

255.31

Depreciation

-75.31

-69.77

-68

-31.04

Tax paid

-115.34

-93.93

-79.57

-87.33

Working capital

-358.09

332.24

134.44

87.45

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

25.63

17.03

24.36

16.12

Op profit growth

25.24

24.27

28.21

11.1

EBIT growth

25.47

22.51

23.92

10.42

Net profit growth

22.82

25.5

32.85

10.16

View Ratios
Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

2,461.4

2,226.6

2,016.9

2,087.4

1,581.3

Excise Duty

0

0

0

0

0

Net Sales

2,461.4

2,226.6

2,016.9

2,087.4

1,581.3

Other Operating Income

0

0

0

0

0

Other Income

93.4

69.2

41.7

52.5

51.3

Dr Lal Pathlabs Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Max Healthcare Institute Ltd

MAXHEALTH

1,107.4

131.821,07,645.29138.240.14697.481.72

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

6,992.5

83.661,00,542.86341.60.232,054.8569.62

Fortis Healthcare Ltd

FORTIS

667.2

250.0450,401.0139.560.15366.87120.23

Narayana Hrudayalaya Ltd

NH

1,775.8

84.5736,292.4479.220.23865.0495.32

Global Health Ltd

MEDANTA

1,177.8

80.5931,624.8299.310624.4113.49

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Dr Lal Pathlabs Ltd

Management

Register Office

Registrar Office

Executive Chairman

Arvind Lal

Whole-time Director

Vandana Lal

Non Executive Director

Archana Lal Erdmann

Non Executive Director

Rahul Sharma

Independent Director

Somya Satsangi

Independent Director

Rohit Bhasin

Independent Director

Arun Duggal

Independent Director

Gurinder Singh Kalra

Independent Director

RAJIT MEHTA

Company Sec. & Compli. Officer

Vinay Gujral

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Dr. Lal PathLabs Limited was incorporated as a Private Limited Company with the name Dr. Lal PathLabs Private Limited, on February 14, 1995 at Delhi. The business of the Partnership Firm, Central Clinical Laboratory was undertaken by the Company. The Company converted into a Public Limited Company and name of the Company was changed to Dr. Lal PathLabs Limited vide fresh Certificate of Incorporation granted by the RoC on August 19, 2015.Dr Lal PathLabs is among the most trusted diagnostic healthcare service provider in India, offering services through over 5000 diagnostic tests and related healthcare services through a nationwide network of medical laboratory centres. Through its integrated, nationwide network, the Company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.Presently, the Company is engaged the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company has built a national, hub and spoke network that includes its National Reference Laboratory in New Delhi, Regional Reference Lab in Kolkata and 371 other clinical laboratories, 5,102 patient service
Read More

Company FAQs

What is the Dr Lal Pathlabs Ltd share price today?

The Dr Lal Pathlabs Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹2777.8 today.

What is the Market Cap of Dr Lal Pathlabs Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr Lal Pathlabs Ltd is ₹23220.11 Cr. as of 29 Apr ‘25

What is the PE and PB ratio of Dr Lal Pathlabs Ltd?

The PE and PB ratios of Dr Lal Pathlabs Ltd is 47.22 and 11.00 as of 29 Apr ‘25

What is the 52 Week High and Low of Dr Lal Pathlabs Ltd?

The 52-week high/low is the highest and lowest price at which a Dr Lal Pathlabs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Dr Lal Pathlabs Ltd is ₹2201.2 and ₹3653.95 as of 29 Apr ‘25

What is the CAGR of Dr Lal Pathlabs Ltd?

Dr Lal Pathlabs Ltd's CAGR for 5 Years at 12.00%, 3 Years at 2.23%, 1 Year at 18.36%, 6 Month at -9.08%, 3 Month at 0.68% and 1 Month at 15.77%.

What is the shareholding pattern of Dr Lal Pathlabs Ltd?

The shareholding pattern of Dr Lal Pathlabs Ltd is as follows:
Promoters - 53.91 %
Institutions - 39.99 %
Public - 5.84 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.